AstraZeneca PLC is 115.4x more valuable than Kailera Therapeutics, Inc. by market capitalization ($286.27 B vs $2.48 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | KLRA | AZN |
|---|---|---|
| Market cap | $2.48 B | $286.27 B |
| US-listed rank | #1952 | #45 |
| SEC filings | 52 | 1,004 |
AstraZeneca PLC is 115.4x more valuable than Kailera Therapeutics, Inc. by market capitalization ($286.27 B vs $2.48 B).
Full pages: Kailera Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.